Alphamab Oncology is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative cancer therapies. Focusing on the Chinese and global mark... Alphamab Oncology is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of innovative cancer therapies. Focusing on the Chinese and global markets, the company is committed to addressing unmet medical needs in oncology. Its primary aim is to leverage advanced multi-functional biologic drug technology to develop next-generation antibody drugs, such as bispecific antibodies, which have the potential to target multiple pathways in cancer cells. Alphamab Oncology’s pipeline is robust, including both clinical and pre-clinical stage products, with a particular emphasis on immune-oncology. The company operates across multiple cancer indications, including gastric cancer, breast cancer, and colorectal cancer, aiming to provide effective treatments that enhance patient outcomes. In the financial market, Alphamab Oncology plays a significant role as a representative of innovative biotech ventures from China, attracting interest from investors seeking exposure to pioneering healthcare solutions and advancements. Positioned at the intersection of biotech innovation and clinical applications, Alphamab Oncology contributes to the evolution of cancer treatment, while also being a notable player in the pharmaceutical sector’s response to global health challenges.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Alphamab Oncology is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Alphamab Oncology is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Alphamab Oncology's data?

Start your 30-day free trial to request a data review for Alphamab Oncology.

Start Free Trial

Legal Center Contact Us